SOPHiA GENETICS Promotes Ross Muken to President, Names George Cardoza as Chief Financial Officer

Ross Muken, President, SOPHiA GENETICS ● Photo Credit: SOPHiA GENETICS

Corporate Business News Sponsored by Business Watch Global

BOSTON and ROLLE, Switzerland, Nov. 7, 2024 (VSNewsNetwork.com) - Healthcare technology company, SOPHiA GENETICS, has announced two key executive appointments. Ross Muken, previously serving as Chief Financial Officer (CFO) and Chief Operating Officer (COO), has been promoted to President, while George Cardoza joins as the company’s new CFO.

George Cardoza, Chief Financial Officer, SOPHiA GENETICS ● Photo Credit: SOPHiA GENETICS

In his new role, Muken will oversee global business operations and support strategic planning alongside CEO Jurgi Camblong. He continues to lead SOPHiA GENETICS' go-to-market functions, including clinical sales, marketing, customer experience, and operations. Muken initially joined SOPHiA GENETICS in 2021 as CFO and was appointed as COO in 2023.

"I want to congratulate Ross on his well-deserved promotion to President. Ross has been an instrumental part of our success since he joined almost four years ago, first as CFO and more recently as COO. I am grateful for his trusted partnership in positioning SOPHiA GENETICS for long-term growth," said Jurgi Camblong, SOPHiA GENETICS CEO and Co-Founder.

@VSNewsNetwork

@VSNewsNetwork

In welcoming Cardoza, Camblong added, "I am also delighted to welcome George Cardoza to our executive leadership team. George is a proven business leader and brings a wealth of deep financial expertise, leadership experience, and industry knowledge to SOPHiA GENETICS. As we continue to grow, George is uniquely qualified to help us succeed in this next exciting chapter of our journey. The leadership of both Ross and George will be crucial as we continue to further enhance our operational effectiveness while also balancing our need to consistently innovate."

As CFO, Cardoza will manage corporate finance functions, including financial planning, accounting, and investor relations. He brings over 30 years of experience in precision medicine and clinical diagnostics, including previous roles as CFO and Head of Service Delivery at Biocartis, and multiple executive positions at NeoGenomics Laboratories.

SOPHiA GENETICS is a cloud-native healthcare technology firm specializing in data-driven medicine, with a mission to use AI to expand access to advanced healthcare insights worldwide.

For more information, visit www.SOPHiAGENETICS.COM.

Source: SOPHiA GENETICS